According to the research report, the global soft tissue sarcoma treatment market was valued at USD 1,341.59 million in 2022 and is expected to reach USD 3,704.27 million by 2032, to grow at a CAGR of 10.7% during the forecast period.
Soft Tissue Sarcoma Treatment Market: Predicted to Reach USD 3,704.27 Million by 2032 | CAGR 10.7%